Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective and Retrospective Observational Real-world Study to Characterize Patients With COPD on Dupilumab Long-term Treatment, and Assess Safety and Patient Reported Outcomes

NCT07380711 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07380711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07380711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective and Retrospective Observational Real-world Study to Characterize Patients With COPD on Dupilumab Long-term Treatment, and Assess Safety and Patient Reported Outcomes
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
January 28, 2026
Completion date
August 14, 2030
Enrollment
500 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease copd